PRESS RELEASE published on 03/23/2026 at 07:30, 2 months 26 days ago Informations privilégiées / Autres communiqués Sensorion publie les données à six mois de l’essai clinique de Phase 1/2 Audiogene pour SENS-501 et poursuit le développement clinique du GJB2-GT (SENS-601) vers une première administration chez l’homme Essai Clinique Thérapie Génique Sensorion Surdité GJB2-GT
BRIEF published on 03/18/2026 at 07:35, 3 months ago Sensorion publie ses résultats 2025 et les dernières nouvelles de l'entreprise Résultats Financiers Thérapie Génique Sensorion Perte Auditive Investissements Sanofi
BRIEF published on 03/18/2026 at 07:35, 3 months ago Sensorion Reports 2025 Results and Corporate Updates Financial Results Gene Therapy Sensorion Hearing Loss Sanofi Investment
PRESS RELEASE published on 03/18/2026 at 07:30, 3 months ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion publie ses résultats annuels 2025, met à jour sa feuille de route et annonce la publication du rapport annuel, avec des avancées significatives dans les thérapies géniques pour la perte auditive Résultats Annuels Bilan Financier Thérapies Géniques Sensorion Perte Auditive
PRESS RELEASE published on 03/18/2026 at 07:30, 3 months ago Inside Information / News release on accounts, results Sensorion reports full-year 2025 results, provides corporate update, and announces release of annual report. Key milestones in gene therapies for hearing loss. Financial highlights and future expectations highlighted Financial Highlights Full-year Results Sensorion Gene Therapies Future Milestones
BRIEF published on 02/17/2026 at 07:35, 4 months 1 day ago Sensorion annonce des changements dans sa direction Sensorion Changement Direction Thérapie Auditive Financement Sanofi Pipeline Médical
BRIEF published on 02/17/2026 at 07:35, 4 months 1 day ago Sensorion announces changes in its management Change Of Direction Sensory Auditory Therapy Sanofi Financing Medical Pipeline
BRIEF published on 02/17/2026 at 07:35, 4 months 1 day ago Leadership Transition at Sensorion amid Strategic Focus on Hearing Loss Therapies Biotechnology Gene Therapy Leadership Change Sensorion Hearing Loss
BRIEF published on 02/17/2026 at 07:35, 4 months 1 day ago Transition de direction chez Sensorion dans un contexte de recentrage stratégique sur les thérapies contre la perte auditive Biotechnologie Thérapie Génique Changement De Leadership Sensorion Perte Auditive
PRESS RELEASE published on 02/17/2026 at 07:30, 4 months 1 day ago Informations privilégiées / Autres communiqués Sensorion annonce des changements dans sa direction avec le départ de Nawal Ouzren et la prise de fonction par Amit Munshi en tant que Directeur Général par intérim Direction Sensorion Changements Amit Munshi Nawal Ouzren
Published on 06/19/2026 at 04:30, 37 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 hours 47 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 4 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 5 hours 7 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 03:35, 1 hour 31 minutes ago From Father's Day to Summer Getaways: How Oxygen Support Helps Protect Health During Europe's Peak Travel Season
Published on 06/19/2026 at 03:00, 2 hours 6 minutes ago HARDHITTER Showcases Global Leading EV Charging Infrastructure Solutions at Power2Drive Europe 2026
Published on 06/19/2026 at 01:15, 3 hours 51 minutes ago UV Laser Technology Gains Momentum in Europe for Clean, Cold Marking and High-Precision Engraving
Published on 06/18/2026 at 22:35, 6 hours 31 minutes ago Bitmine Immersion Technologies Announces Cash Dividend of $0.1056 per Share of 9.50% Series A Perpetual Preferred Stock
Published on 06/18/2026 at 22:00, 7 hours 7 minutes ago Blue Cap AG: Closing of the Acquisition of Janoschka AG Successfully Completed
Published on 06/18/2026 at 18:00, 11 hours 7 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mai 2026
Published on 06/18/2026 at 18:00, 11 hours 7 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 11 hours 22 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:45, 11 hours 22 minutes ago EURAZEO INVESTIT DANS LAURALU, ACTEUR PANEUROPÉEN SPÉCIALISTE DES INFRASTRUCTURES INDUSTRIELLES DÉPLOYABLES
Published on 06/18/2026 at 17:45, 11 hours 22 minutes ago ASSEMBLEE GENERALE DU 16 JUIN 2026 : COMPTE-RENDU ET RESULTATS DES VOTES
